A

Asceneuron SA

17 employees

Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Basic info

Industry

biotechnology research

Sectors

Tauopathies
Biotechnology
Novel Therapeutics
Health Care
Parkinson's disease
Neurodegeneration
Therapeutics
Small Molecule Drug Discovery
Orphan Diseases
PSP
Alzheimer's disease

Date founded

2012

Funding rounds raised

Total raised

$31M

from 3 investors over 3 rounds

A

Asceneuron SA raised $31M on September 29, 2015

Investors: Sofinnova Partners, S.R. One Ltd and M Ventures

FAQ